Zithromax Injection, Powder, Lyophilized, For Solution
Product Images NDC 0069-3150

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Zithromax (NDC 0069-3150). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pfizer Laboratories Div Pfizer Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Zithromax Iv 01)

FDA Label Image

Logo (Zithromax Iv 02)

Logo (Zithromax Iv 02)
This is a description of a product called "Iniectables" being distributed by Plizer Labs, which is a division of Pfizer Inc located in New York, NY 10017.*
FDA Label Image

Principal Display Panel (500 mg Vial Label)

FDA Label Image

Principal Display Panel (10 Vials Carton)

Principal Display Panel (10 Vials Carton)
This is a description of "Zithromax®"(azithromycin) for intravenous use only. It contains 10 single-dose vials with 500 mg/vial of azithromycin powder for injection, which is equivalent to 10500 mg of sahromycin. The powder must be reconstituted by adding 4.8L of sterile water. Once reconstituted, it maintains its potency for 24 hours at room temperature and must be further diluted before use. The directions for proper dilution and storage are included in the prescribing information. It is made by Pfizer Labs, and it is manufactured in Ireland.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.